Clinical Trial Update: T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies [Phase 1, Phase 2]

View source ↗

Summary

A trial investigating T-regulatory cell and CD3-depleted double umbilical cord blood transplantation for hematologic malignancies has been withdrawn (Phase 1/Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Burkitt Lymphoma
• Chronic Lymphocytic Leukemia
• Follicular Lymphoma
• Mantle Cell Lymphoma
• Myelogenous Leukemia in Blast Crisis
• Small Lymphocytic Lymphoma

Drugs mentioned

• T-regulatory cell and CD3-depleted double umbilical cord blood transplantation

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Hematologic Malignancy, Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: WITHDRAWN